Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age
Clinical trial NCT04893811 · COMPLETED
Trial details
- NCT number
- NCT04893811
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-18
- Primary completion
- 2023-09-06
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.